Poseida Therapeutics, Inc. (PSTX)
Total Valuation
PSTX has a market cap or net worth of $167.11 million. The enterprise value is $76.82 million.
Market Cap | 167.11M |
Enterprise Value | 76.82M |
Important Dates
The next earnings date is Thursday, August 11, 2022, before market open.
Estimated Earnings Date | Aug 11, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
PSTX has 62.70 million shares outstanding. The number of shares has increased by 0.93% in one year.
Shares Outstanding | 62.70M |
Shares Change (YoY) | +0.93% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 40.83% |
Owned by Institutions (%) | 43.42% |
Float | 32.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.11 |
PB Ratio | 1.61 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.90.
Current Ratio | 4.34 |
Quick Ratio | 4.18 |
Debt / Equity | 0.90 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -97.00%, which is considered low. The company has a ROIC of -143.50%.
Return on Equity (ROE) | -97.00% |
Return on Assets (ROA) | -53.70% |
Return on Capital (ROIC) | -143.50% |
Revenue Per Employee | $115,452 |
Profits Per Employee | -$511,367 |
Employee Count | 283 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.79% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -68.79% |
50-Day Moving Average | 2.22 |
200-Day Moving Average | 3.85 |
Average Volume (30 Days) | 254,055 |
Short Selling Information
The latest short interest is 1.94 million, so 3.09% of the outstanding shares have been sold short.
Short Interest | 1.94M |
Short % of Shares Out | 3.09% |
Short % of Float | 5.93% |
Short Ratio (days to cover) | 12.59 |
Income Statement
In the last 12 months, PSTX had revenue of $32.67 million and -144.72 million in losses. Earnings per share was -$2.32.
Revenue | 32.67M |
Gross Profit | 32.67M |
Operating Income | -160.91M |
Net Income | -144.72M |
EBITDA | -136.43M |
EBIT | -141.12M |
Earnings Per Share (EPS) | -$2.32 |
Balance Sheet
The company has $183.49 million in cash and $93.20 million in debt, giving a net cash position of $90.29 million or $1.44 per share.
Cash & Cash Equivalents | 183.49M |
Total Debt | 93.20M |
Net Cash | 90.29M |
Net Cash Per Share | $1.44 |
Book Value | 103.70M |
Book Value Per Share | 1.65 |
Working Capital | 146.59M |
Cash Flow
In the last 12 months, operating cash flow was -$114.81 million and capital expenditures -$2.88 million, giving a free cash flow of -$117.70 million.
Operating Cash Flow | -114.81M |
Capital Expenditures | -2.88M |
Free Cash Flow | -117.70M |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -492.48% and -442.93%.
Gross Margin | 100.00% |
Operating Margin | -492.48% |
Pretax Margin | n/a |
Profit Margin | -442.93% |
EBITDA Margin | -417.57% |
EBIT Margin | -431.92% |
FCF Margin | -360.22% |
Dividends & Yields
PSTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -86.60% |
FCF Yield | -70.43% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.93% |
Shareholder Yield | -0.93% |
Analyst Forecast
The average price target for PSTX is $16.58, which is 522.14% higher than the current price. The consensus rating is "Buy".
Price Target | $16.58 |
Price Target Difference | 522.14% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |